21. Sympathoadrenal Hyperactivity And The Etiology Of Neuroleptic Sympathoadrenal Hyperactivity and the Etiology of neuroleptic malignant syndrome Ronald J. Gurrera, M.D. ABSTRACT http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

22. Symptoms Of Neuroleptic Malignant Syndrome - WrongDiagnosis.com Symptoms of neuroleptic malignant syndrome including signs, symptoms, incubationperiod, duration, and correct diagnosis. http://www.wrongdiagnosis.com/n/neuroleptic_malignant_syndrome/symptoms.htm

Home Symptoms Diseases Risks ... Neuroleptic Malignant Syndrome Search our medical database Subscribe to our free Newsletter sample Send this page to a friend Condition Lists By Organ By Symptom By Class By Prevalence ... List A-Z Current chapter: Neuroleptic Malignant Syndrome Next sections Misdiagnosis of Medication Causes of Neuroleptic Malignant Syndrome Treatments for Neuroleptic Malignant Syndrome Doctors and Medical Specialists for Neuroleptic Malignant Syndrome Articles about Neuroleptic Malignant Syndrome ... Glossary for Neuroleptic Malignant Syndrome Next chapters: Schizencephaly Niemann-Pick disease Occipital Neuralgia Chronic pain ... Feedback Symptoms of Neuroleptic Malignant Syndrome General information about symptoms of Neuroleptic Malignant Syndrome: The symptom information on this page attempts to provide a list of some possible symptoms of Neuroleptic Malignant Syndrome. This symptom information has been gathered from various sources, may not be fully accurate, and may not be the full list of symptoms of Neuroleptic Malignant Syndrome. Furthermore, symptoms of Neuroleptic Malignant Syndrome may vary on an individual basis for each patient. Only your doctor can provide adequate diagnosis of symptoms and whether they are indeed symptoms of Neuroleptic Malignant Syndrome. List of symptoms of Neuroleptic Malignant Syndrome: The list of symptoms mentioned in various sources for Neuroleptic Malignant Syndrome includes: High fever Sweating Unstable blood pressure Stupor ... Autonomic dysfunction Symptoms of Neuroleptic Malignant Syndrome:

23. Neuroleptic Malignant Syndrome A Review Pelonero Et Al. 49 neuroleptic malignant syndrome A Review Anthony L. Pelonero, M.D. , James L. Levenson, M.D. and Anand K. Pandurangi, M.D. http://tmsyn.wc.ask.com/r?t=an&s=hb&uid=24312681243126812&sid=343126

24. Psychiatric Times neuroleptic malignant syndrome Best Treated as Catatonia. by Max Fink, MD NMSIS (2000), neuroleptic malignant syndrome Information Service. http://www.psychiatrictimes.com/p001128.html

25. Neuroleptic Malignant Syndrome neuroleptic malignant syndrome is a rare but potentially life threateningreaction to the use of almost http://my.webmd.com/hw/schizophrenia/nord763.asp

var guid_source = ""; var guid_source_id = ""; //unused var encodedurl = ""; WebMD Today Home WebMD News Center XML News via RSS Member Services WebMD University My WebMD Find a Physician Medical Info Check Symptoms Medical Library Health Tools Clinical Trials ... Women, Men, Lifestyle Who We Are About WebMD Site Map You are in All Conditions ADD/ADHD Allergies Alzheimer's Arthritis Asthma Back Pain Bipolar Disorder Breast Cancer Cancer Cholesterol Management Dental Depression Diabetes Epilepsy Eye Health Heart Disease Hepatitis HIV/AIDS Hypertension Men's Conditions Mental Health Migraines/Headaches Multiple Sclerosis Osteoporosis Parkinson's Sexual Conditions Stroke Weight Control Women's Conditions Health Topics Symptoms Medical Tests Medications ... For a Complete Report Neuroleptic Malignant Syndrome Important It is possible that the main title of the report Neuroleptic Malignant Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report. Synonyms Drug-Induced Movement Disorder Neuroleptic-Induced Acute Dystonia Hyperthermia Disorder Subdivisions None General Discussion Neuroleptic malignant syndrome is a rare but potentially life-threatening reaction to the use of almost any of a group of antipsychotic drugs or major tranquilizers (neuroleptics). These drugs are commonly prescribed for the treatment of schizophrenia and other neurological, mental, or emotional disorders. Several of the more commonly prescribed neuroleptics include thioridazine, haloperidol, chlorpromazine, fluphenazine and perphenazine.

26. Annals Of General Psychiatry | Full Text | Olanzapine-associated Neuroleptic Mal Olanzapineassociated neuroleptic malignant syndrome Is there an overlap with The neuroleptic malignant syndrome is a rare but serious condition mainly http://www.annals-general-psychiatry.com/content/2/1/10

Home Browse articles Supplements Search ... Volume 2 Viewing options Abstract Full text PDF Associated material: Comments (1) PubMed record Related literature: Articles citing this article on Google Scholar Other articles by authors Kontaxakis VP ... Similar articles (PubMed) Tools: E-mail to a friend Download references Post a comment Key E-mail Corresponding author Primary research Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Vassilis P Kontaxakis Beata J Havaki-kontaxaki Nikolaos G Christodoulou Konstantinos G Paplos and George N Christodoulou Department of Psychiatry, University of Athens, Eginition Hospital, Athens, Greece Annals of General Hospital Psychiatry The electronic version of this article is the complete one and can be found online at: http://www.general-hospital-psychiatry.com/content/2/1/10 Received Accepted Published Keywords: neuroleptic malignant syndrome, serotonin syndrome, olanzapine Outline Abstract Abstract Background Methods Results ... References Background The neuroleptic malignant syndrome is a rare but serious condition mainly associated with antipsychotic medication. There are controversies as to whether "classical" forms of neuroleptic malignant syndrome can occur in patients given atypical antipsychotics. The serotonin syndrome is caused by drug-induced excess of intrasynaptic 5-hydroxytryptamine. The possible relationship between neuroleptic malignant syndrome and serotonin syndrome is at present in the focus of scientific interest. Methods Results

27. Entrez PubMed BACKGROUND The neuroleptic malignant syndrome is a rare but serious condition The possible relationship between neuroleptic malignant syndrome and http://www.annals-general-psychiatry.com/pubmed/14613516

My NCBI [Sign In] [Register] All Databases ... Books Search PubMed Protein Nucleotide Structure Genome Books CancerChromosomes Conserved Domains 3D Domains Gene Genome Project GENSAT GEO Profiles GEO DataSets HomoloGene Journals MeSH NCBI Web Site NLM Catalog OMIA OMIM PMC PopSet Probe PubChem BioAssay PubChem Compound PubChem Substance SNP Taxonomy UniGene UniSTS for Limits Preview/Index History Clipboard Details About Entrez Text Version Entrez PubMed Overview FAQ Tutorial New/Noteworthy ... E-Utilities PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher ... Cubby Related Resources Order Documents NLM Mobile NLM Catalog NLM Gateway ... PubMed Central Display Summary Brief Abstract Citation MEDLINE XML UI List LinkOut ASN.1 Related Articles Cited Articles Cited in Books CancerChrom Links Domain Links 3D Domain Links GEO DataSet Links Gene Links Gene (GeneRIF) Links Genome Links Project Links GENSAT Links GEO Profile Links HomoloGene Links Nucleotide Links OMIA Links OMIM Links BioAssay Links Compound Links Compound via MeSH Substance Links Substance via MeSH PMC Links Cited in PMC PopSet Links Probe Links Protein Links SNP Links Structure Links UniGene Links UniSTS Links Show Sort by Author Journal Pub Date Send to Text File Clipboard E-mail Order All: 1 Review: Ann Gen Hosp Psychiatry.

28. Neuroleptic Malignant Syndrome - Wikipedia, The Free Encyclopedia neuroleptic malignant syndrome (NMS) is a lifethreatening, Neuroleptic MalignantSyndrome By Darius P Sholevar, MD and Ellen H Solevar, MD. http://en.wikipedia.org/wiki/Neuroleptic_malignant_syndrome

You did it! Over US$240,000 was donated in the 21 day fund drive. Thank you for your generosity! You are still welcome to make a donation or purchase Wikimedia merchandise Neuroleptic malignant syndrome From Wikipedia, the free encyclopedia. Neuroleptic malignant syndrome (NMS) is a life-threatening, neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic drugs . It is considered to be a very serious neurological disorder. Contents Causes Symptoms Prognosis Treatment ... edit Causes NMS is caused almost exclusively by antipsychotics, which includes all types of neuroleptic medicines along with newer antipsychotic drugs. The higher the dosage, the more common the occurrence. Rapid and large increases in dosage can also be attributed to the development of NMS. Other drugs, environmental or psychological factors, hereditary conditions, and specific demographics may be at greater risk, but to date no conclusive evidence has been found to support this. The disorder typically develops within two weeks of the initial treatment with the drug, but may develop at any time that the drug is being taken. NMS may also occur in people taking a class of drugs known as dopaminergics edit Symptoms The first symptom to develop is usually muscular rigidity, followed by high

29. Neuroleptic Malignant Syndrome - Welcome To The National Parkinson Foundation To find the cause of and the cure for Parkinson disease through research.To improvethe quality of life for both patients and caregivers with Parkinson http://www.parkinson.org/site/pp.asp?c=9dJFJLPwB&b=100151

30. About Neuroleptic Malignant Syndrome Free information and resources on counselling and psychotherapy, mental healthand wellness plus lowcost online therapy. http://counsellingresource.com/medications/medication-types/about-nms.html

Information on Neuroleptic Malignant Syndrome This life-threatening neurological disorder is usually caused by an adverse reaction to anti-psychotic, or neuroleptic drugs. What is Neuroleptic Malignant Syndrome? Is there any treatment? What is the prognosis? What research is being done? ... Organizations What is Neuroleptic Malignant Syndrome? Neuroleptic malignant syndrome is a life-threatening, neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic drugs. Symptoms include high fever, sweating, unstable blood pressure, stupor, muscular rigidity, and autonomic dysfunction. In most cases, the disorder develops within the first 2 weeks of treatment with the drug; however, the disorder may develop any time during the therapy period. The syndrome can also occur in people taking anti-Parkinsonism drugs known as dopaminergics if those drugs are discontinued abruptly. Is there any treatment? Generally, intensive care is needed. The neuroleptic or antipsychotic drug is discontinued, and the fever is treated aggressively. A muscle relaxant may be prescribed. Dopaminergic drugs, such as a dopamine agonist, have been reported to be useful. What is the prognosis?

31. Neuroleptic Malignant Syndrome Induced By Quetiapine And To the Editor neuroleptic malignant syndrome is induced less by atypical Hence, in this case, neuroleptic malignant syndrome may have been caused by a http://ajp.psychiatryonline.org/cgi/content/full/162/4/812

32. Possible Neuroleptic Malignant Syndrome With Aripiprazole And To the Editor There are rare reports of neuroleptic malignant syndrome occurringwith a combination of atypical antipsychotics and selective serotonin http://ajp.psychiatryonline.org/cgi/content/full/162/2/397-a

33. Neuroleptic Malignant Syndrome neuroleptic malignant syndrome. Idiopathic reaction occurring after treatmentwith neuroleptics such as haloperidol or fluphenazine. http://www.aic.cuhk.edu.hk/web8/neuroleptic malig syn.htm

All these topics are covered in the Not so BASIC course. Click here for details Neuroleptic malignant syndrome Idiopathic reaction occurring after treatment with neuroleptics such as haloperidol or fluphenazine. May occur at any point in anti-psychotic drug therapy with either high or low potency neuroleptics, although usually occurs within 4 weeks of starting therapy May also follow: multiple changes from one neuroleptic to another discontinuation of anti-Parkinsonian drugs administration or rapid increase in dose of potent domapine antagonists Clinical features hyperthermia and muscle rigidity are always present increased muscle tone may lead to decreased chest wall compliance producing tachypnoeic hypoventilation severe enough to require ventilation motor abnormalities range from akinesia to involuntary movements and fluctuating tremors rigidity and akinesia develop concurrently or shortly before pyrexia impaired consciousness autonomic dysfunction causing sweating, tachycardia and labile blood pressure infrequent findings include: oculogyric crises opisthotonus seizures chorea extensor plantars trismus Clinical course develops insidiously over 1-3 days, usually early in a course of treatment or when the dose of drug is increased

34. Neuroleptic Malignant Syndrome neuroleptic malignant syndrome. This occurs in 0.51% patients. Untreated mortalityis 20%. Signs and Symptoms In Summary MUSCAT © psychejam 2000 http://www.psychejam.com/neuroleptic_malignant_syndrome.htm

35. Neuroleptic Malignant Syndrome - Enpsychlopedia neuroleptic malignant syndrome (NMS) is a lifethreatening, neurological disordermost often NINDS neuroleptic malignant syndrome Information Page http://psychcentral.com/psypsych/Neuroleptic_malignant_syndrome

home resource directory disorders quizzes ... support forums Neuroleptic malignant syndrome Neuroleptic malignant syndrome (NMS) is a life-threatening, neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic drugs . It is considered to be a very serious neurological disorder. Contents showTocToggle("show","hide") 1 Causes 2 Symptoms 3 Prognosis 4 Treatment ... edit Causes NMS is caused almost exclusively by antipsychotics, which includes all types of neuroleptic medicines along with newer antipsychotic drugs. The higher the dosage, the more common the occurrence. Rapid and large increases in dosage can also be attributed to the development of NMS. Other drugs, environmental or psycological factors, hereditary conditions, and specific demographics may be at greater risk, but to date no conclusive evidence has been found to support this. The disorder typically develops within two weeks of the initial treatment with the drug, but may develop at any time that the drug is being taken. NMS may also occur if people taking a class of drugs known as dopaminergics discontinue use abruptly.

36. Neuroleptic Malignant Syndrome Diction neuroleptic malignant syndrome. neuroleptic malignant syndrome isthe rarest of the neuroleptic induced movement disorders. http://www.psyweb.com/Glossary/nms.jsp

37. What Is Neuroleptic Malignant Syndrome This site contains valuable information about neuroleptic malignant syndrome. http://www.mamashealth.com/syndrome/neuro.asp

Mamashealth.com Home Syndromes Pages Neuroleptic Malignant Nighttime Eating Patellofemoral Pain Piriformis ... Zollinger-Ellison Links More Syndromes Email Mama What is Neuroleptic Malignant Syndrome? Neuroleptic malignant syndrome is a rare, life-threatening, neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic drugs. In most cases, the neuroleptic malignant syndrome develops within the first 2 weeks of treatment with the drug. However, neuroleptic malignant syndrome may develop any time during the therapy period. It can also occur in people taking anti-Parkinsonism drugs known as dopaminergics if those drugs are discontinued abruptly. What Causes Neuroleptic Malignant Syndrome? Neuroleptic malignant syndrome is usually caused by negative reaction reaction to the use of almost any of a group of antipsychotic drugs or major tranquilizers. Antipsychotic drugs and/or major tranquilizers are commonly prescribed for the treatment of schizophrenia and other neurological, mental, or emotional disorders. Some of the more commonly prescribed neuroleptics include thioridazine, haloperidol, chlorpromazine, fluphenazine and perphenazine. What are the Symptoms of Neuroleptic Malignant Syndrome?

38. Schizophrenia Daily News Blog Identify Neuroleptic Malignant Syndrome See Full Story Identify neuroleptic malignant syndrome with FEVER. Posted byszadmin at July 5, 2005 1103 PM More Information on Schizophrenia Medications http://www.schizophrenia.com/sznews/archives/002054.html

Advertisement document.write(''); Home About Donate/Volunteer Contact ... Schizophrenia Daily News Blog Daily Schizophrenia-related news, commentary and links to additional information. Main July 05, 2005 Identify neuroleptic malignant syndrome filed under Schizophrenia Medications Clinical Psychiatry Online, in this month's issue, highlights the uncommon, but deadly side effect of anti-psychotic medications called "NMS", or Neuroleptic malignant syndrome, which is a type of hypothermia (low body temperature) which can be halted immediately by discontinuation of the drug. The journal article, (written for doctors, but probably understandable to most lay audiences) describes the diagnosis of the problem using the mnemonic "FEVER" (as a memory trigger). According to this article, FEVER stands for: Fever. Hyperthermia is often considered NMS’ hallmark and distinguishes it from other acute neuropsychiatric disorders. Encephalopathy . Patients may abruptly and unexpectedly become confused, obtunded, and disoriented during early or prodomal NMS stages. Vital sign instability Enzyme elevation.

39. Schizophrenia Daily News Blog: Comment On Identify Neuroleptic Malignant Syndrom Comments Identify neuroleptic malignant syndrome. return to the entry page.It is not often that I come across an article that addresses sexual health in http://www.schizophrenia.com/cgi-bin/mt/mt-comments.cgi?entry_id=2054

40. Neuroleptic Malignant Syndrome Due To Three Atypical Antipsychotics In A Child - neuroleptic malignant syndrome (NMS) is a rare, potentially fatal and idiosyncraticdrug reaction. It is characterized by a sudden loss of body temperature http://jop.sagepub.com/cgi/content/abstract/19/4/422

JOURNAL HOME HELP CONTACT US SUBSCRIPTIONS ... TABLE OF CONTENTS QUICK SEARCH: [advanced] Author: Keyword(s): Year: Vol: Page: Journal of Psychopharmacology, Vol. 19, No. 4, 422-425 (2005) DOI: 10.1177/0269881105053310 This Article Full Text (PDF) References Alert me when this article is cited ... Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal ... Download to citation manager PubMed PubMed Citation Articles by Chungh, D.-S. Articles by Cho, S.-C. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child Dong-Seon Chungh Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Bundang Hospital, Seoul, Korea. Boong-Nyun Kim Division of Child and Adolescent Psychiatry, Department of psychiatry, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea. Soo-Churl Cho Division of Child and Adolescent Psychiatry, Department of psychiatry, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 2     21-40 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20